| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | UmuC | 3.13e-06 | 6 | 102 | 3 | IPR001126 | |
| Domain | IMS | 1.76e-04 | 4 | 102 | 2 | PF00817 | |
| Domain | IMS_C | 1.76e-04 | 4 | 102 | 2 | PF11799 | |
| Domain | UMUC | 1.76e-04 | 4 | 102 | 2 | PS50173 | |
| Domain | - | 1.76e-04 | 4 | 102 | 2 | 3.30.1490.100 | |
| Domain | FGF_rcpt_fam | 1.76e-04 | 4 | 102 | 2 | IPR016248 | |
| Domain | DNA_pol_Y-fam_little_finger | 1.76e-04 | 4 | 102 | 2 | IPR017961 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 SETX ARID4B CALD1 CHD7 SSRP1 ZNF711 LENG8 PRPF3 ZNF644 ZNF451 SMARCC1 UTP3 DEK SNRNP200 TOP2A NOL8 | 4.85e-09 | 954 | 106 | 17 | 36373674 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SETX RNF168 ARID4B CHD7 SSRP1 EZH2 PPM1G ZNF711 ZNF644 ZNF451 SMARCC1 DEK TOP2A SENP7 | 5.19e-09 | 608 | 106 | 14 | 36089195 |
| Pubmed | CYLC1 NOLC1 CALD1 SYNE1 ABCB5 ANKRD30B CAGE1 SSRP1 TNRC18 MIA2 MYH14 FAM161A CTR9 DGKK SMARCC1 ATG4C FGFR1 PLS1 ARHGAP21 TOP2A | 1.28e-08 | 1442 | 106 | 20 | 35575683 | |
| Pubmed | NOLC1 SETD1A SETX CHD7 SSRP1 PARP14 EZH2 SMARCC1 CRYBG1 DEK UNC79 TOP2A | 2.20e-08 | 469 | 106 | 12 | 27634302 | |
| Pubmed | 8.22e-08 | 251 | 106 | 9 | 31076518 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 SEC16B GCFC2 ARID4B CHD7 SSRP1 EZH2 CTR9 ZNF644 SMARCC1 SNRNP200 TOP2A SNX2 PPP6R3 | 1.04e-07 | 774 | 106 | 14 | 15302935 |
| Pubmed | NOLC1 FRAS1 ANK3 ACAD9 SYNE1 RTN4 MPDZ SSRP1 PPM1G CTR9 ZNF644 ZNF451 OSBPL8 DEK CSPP1 SNRNP200 SNX2 PPP6R3 NOL8 | 1.12e-07 | 1487 | 106 | 19 | 33957083 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.27e-07 | 283 | 106 | 9 | 30585729 | |
| Pubmed | NOLC1 AARS1 SETX CHD7 SSRP1 HEXIM1 PPM1G LENG8 TNRC18 PRPF3 CTR9 ZNF644 SMARCC1 DEK SNRNP200 TOP2A | 2.39e-07 | 1103 | 106 | 16 | 34189442 | |
| Pubmed | AARS1 ANK3 OXR1 SYNE1 CUL9 CMYA5 BFSP1 CEP350 THOP1 MIA2 MYH14 CTR9 ZNF451 OSBPL8 DNAI7 SNRNP200 ARHGAP21 | 3.51e-07 | 1285 | 106 | 17 | 35914814 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.75e-07 | 148 | 106 | 7 | 32538781 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 AARS1 SETX SASH1 CEP162 SH3GL1 MPDZ SSRP1 DENND4C CEP350 OSBPL8 CSPP1 ARHGAP21 SNX2 | 3.76e-07 | 861 | 106 | 14 | 36931259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NOLC1 AARS1 CALD1 OXR1 SH3GL1 THUMPD3 SSRP1 CMYA5 HEXIM1 PPM1G THOP1 MYH14 CTR9 DEK SNRNP200 PLS1 SNX2 PPP6R3 | 4.06e-07 | 1455 | 106 | 18 | 22863883 |
| Pubmed | AARS1 FRAS1 SETX RTN4 MPDZ EZH2 HEXIM1 CTR9 STARD3 SMARCC1 CLSPN ARHGAP21 | 7.30e-07 | 650 | 106 | 12 | 38777146 | |
| Pubmed | SETD1A CALD1 ANK3 SH3GL1 MPDZ SSRP1 SMARCC1 SNRNP200 TOP2A SNX2 PPP6R3 | 9.88e-07 | 549 | 106 | 11 | 38280479 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A SSRP1 LENG8 PRPF3 MYH14 CTR9 SMARCC1 UTP3 TOP2A PPP6R3 | 1.02e-06 | 440 | 106 | 10 | 34244565 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 AARS1 ACAD9 SYNE1 RTN4 THUMPD3 SSRP1 CMYA5 HEXIM1 MYH14 CTR9 SMARCC1 UTP3 DEK SNRNP200 TOP2A SNX2 | 1.46e-06 | 1425 | 106 | 17 | 30948266 |
| Pubmed | 1.46e-06 | 63 | 106 | 5 | 17672918 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 SH3GL1 SSRP1 HEXIM1 PPM1G LENG8 CTR9 SMARCC1 UTP3 CLSPN DEK SNRNP200 TOP2A NOL8 | 1.93e-06 | 989 | 106 | 14 | 36424410 |
| Pubmed | CHD7 SSRP1 HEXIM1 PPM1G PRPF3 MYH14 CTR9 SCN1A SMARCC1 FGFR1 FGFR3 DEK SNRNP200 PLS1 TGS1 | 2.27e-06 | 1153 | 106 | 15 | 29845934 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | AARS1 ANK3 MYO7A ACAD9 RTN4 OSBPL8 UTP3 DNAI7 CSPP1 ARHGAP21 | 3.04e-06 | 497 | 106 | 10 | 36774506 |
| Pubmed | 3.77e-06 | 209 | 106 | 7 | 36779422 | ||
| Pubmed | CALD1 ANK3 ACAD9 CUL9 SSRP1 EZH2 PPM1G SMARCC1 ARHGAP21 TOP2A PPP6R3 | 3.94e-06 | 634 | 106 | 11 | 34591612 | |
| Pubmed | 4.20e-06 | 403 | 106 | 9 | 35253629 | ||
| Pubmed | Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti. | 4.46e-06 | 11 | 106 | 3 | 17117437 | |
| Pubmed | NOLC1 SETX ANK3 CEP162 PPM1G CEP350 RPGR CLSPN SNRNP200 SDK1 ARHGAP21 NOL8 | 4.59e-06 | 777 | 106 | 12 | 35844135 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.83e-06 | 410 | 106 | 9 | 26949251 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 AARS1 SH3GL1 SSRP1 HEXIM1 PPM1G THOP1 MIA2 PRPF3 CTR9 OSBPL8 SMARCC1 DEK SNRNP200 TOP2A PPP6R3 | 6.05e-06 | 1415 | 106 | 16 | 28515276 |
| Pubmed | ACAD9 RTN4 LENG8 CTR9 OSBPL8 SMARCC1 SNRNP200 TOP2A SNX2 PPP6R3 | 8.64e-06 | 560 | 106 | 10 | 35241646 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | AARS1 ACAD9 RTN4 SH3GL1 MPDZ PPM1G THOP1 CTR9 OSBPL8 SNRNP200 PLS1 SNX2 PPP6R3 | 8.66e-06 | 974 | 106 | 13 | 28675297 |
| Pubmed | 9.04e-06 | 157 | 106 | 6 | 30186101 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 SETX RNF168 ARID4B CHD7 SSRP1 EZH2 PRPF3 CTR9 ZNF644 SMARCC1 DEK SNRNP200 TOP2A NOL8 | 9.08e-06 | 1294 | 106 | 15 | 30804502 |
| Pubmed | Clathrin- and dynamin-independent endocytosis of FGFR3--implications for signalling. | 9.20e-06 | 2 | 106 | 2 | 21779335 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29299828 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16685373 | ||
| Pubmed | TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup. | 9.20e-06 | 2 | 106 | 2 | 28899973 | |
| Pubmed | Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma. | 9.20e-06 | 2 | 106 | 2 | 27237367 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37047518 | ||
| Pubmed | Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. | 9.20e-06 | 2 | 106 | 2 | 1379594 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27055092 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11585811 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 29654068 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19470682 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23468956 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 3875483 | ||
| Pubmed | Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis. | 9.20e-06 | 2 | 106 | 2 | 15558020 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28468611 | ||
| Pubmed | Secreted FGFR3, but not FGFR1, inhibits lens fiber differentiation. | 9.20e-06 | 2 | 106 | 2 | 11290300 | |
| Pubmed | A structural basis for immunodominant human T cell receptor recognition. | 9.20e-06 | 2 | 106 | 2 | 12796775 | |
| Pubmed | FGF8 is essential for formation of the ductal system in the male reproductive tract. | 1.22e-05 | 15 | 106 | 3 | 22110055 | |
| Pubmed | SETX ACAD9 SYNE1 MPDZ CHD7 SSRP1 EZH2 HEXIM1 LENG8 CTR9 ELAPOR1 OSBPL8 CRYBG1 UTP3 PPP6R3 NOL8 | 1.22e-05 | 1497 | 106 | 16 | 31527615 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.27e-05 | 351 | 106 | 8 | 38297188 | |
| Pubmed | 1.29e-05 | 167 | 106 | 6 | 25659891 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.46e-05 | 358 | 106 | 8 | 32460013 | |
| Pubmed | 1.50e-05 | 16 | 106 | 3 | 24145799 | ||
| Pubmed | 1.65e-05 | 103 | 106 | 5 | 32744500 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NOLC1 SCHIP1 SSRP1 DENND4C CEP350 CTR9 ARHGAP29 CRYBG1 CLSPN DEK ARHGAP21 PPP6R3 TGS1 | 1.70e-05 | 1038 | 106 | 13 | 26673895 |
| Pubmed | 1.87e-05 | 486 | 106 | 9 | 20936779 | ||
| Pubmed | 1.90e-05 | 268 | 106 | 7 | 33640491 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NOLC1 CALD1 HEXIM1 CTR9 OSBPL8 AUTS2 FGFR1 FGFR3 CLSPN DEK ARHGAP21 PPP6R3 | 2.22e-05 | 910 | 106 | 12 | 36736316 |
| Pubmed | CALD1 SH3GL1 SH3GL2 MPDZ HEXIM1 PPM1G PRPF3 ARHGAP29 SMARCC1 DEK ARHGAP21 PPP6R3 | 2.36e-05 | 916 | 106 | 12 | 32203420 | |
| Pubmed | 2.57e-05 | 19 | 106 | 3 | 16049112 | ||
| Pubmed | NOLC1 SETX ANK3 ACAD9 CEP162 CHD7 ESCO2 THOP1 CTR9 SMARCC1 CRYBG1 ARHGAP21 TGS1 | 2.66e-05 | 1084 | 106 | 13 | 11544199 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 38008711 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31189094 | ||
| Pubmed | Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations. | 2.76e-05 | 3 | 106 | 2 | 22724017 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28813519 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8382556 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30755670 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23185502 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19728793 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20405041 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20301628 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21614903 | ||
| Pubmed | DNA polymerase ι is acetylated in response to SN2 alkylating agents. | 2.76e-05 | 3 | 106 | 2 | 30886224 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20553372 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33433858 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9286594 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7896824 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29097598 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37666053 | ||
| Pubmed | Enriched Environment Promotes Adult Hippocampal Neurogenesis through FGFRs. | 2.76e-05 | 3 | 106 | 2 | 33637561 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12429093 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22167186 | ||
| Pubmed | Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer. | 2.76e-05 | 3 | 106 | 2 | 24898159 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18216705 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31830366 | ||
| Pubmed | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. | 2.76e-05 | 3 | 106 | 2 | 24850843 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3873654 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 AARS1 CALD1 RTN4 SH3GL1 LENG8 PRPF3 SNRNP200 ARHGAP21 TOP2A PPP6R3 NOL8 | 2.86e-05 | 934 | 106 | 12 | 33916271 |
| Pubmed | NOLC1 SETD1A ARID4B CUL9 CHD7 PPM1G LENG8 LHX1 MYH14 ZNF644 ZNF451 DGKK AUTS2 SMARCC1 PPP6R3 | 2.89e-05 | 1429 | 106 | 15 | 35140242 | |
| Pubmed | NOLC1 AARS1 CUL9 CHD7 PPM1G MYH14 OSBPL8 SMARCC1 SNRNP200 PPP6R3 | 3.21e-05 | 653 | 106 | 10 | 22586326 | |
| Pubmed | 4.33e-05 | 417 | 106 | 8 | 36537216 | ||
| Pubmed | 4.66e-05 | 210 | 106 | 6 | 16565220 | ||
| Pubmed | 4.70e-05 | 128 | 106 | 5 | 30995482 | ||
| Pubmed | Transforming fusions of FGFR and TACC genes in human glioblastoma. | 5.50e-05 | 4 | 106 | 2 | 22837387 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 17414280 | ||
| Pubmed | Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. | 5.50e-05 | 4 | 106 | 2 | 17343269 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 9122235 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 10704861 | ||
| Interaction | H3C1 interactions | SETD1A ARID4B ANK3 SYNE1 CHD7 SSRP1 EZH2 PPM1G ZNF711 ESCO2 TNRC18 PRPF3 MYH14 CTR9 ZNF644 UTP3 DEK DNAH9 TOP2A | 2.13e-07 | 901 | 106 | 19 | int:H3C1 |
| Interaction | ZNF330 interactions | NOLC1 ARID4B CHD7 SSRP1 PPM1G ZNF711 CTR9 ZNF644 SMARCC1 UTP3 DEK TOP2A NOL8 | 6.31e-07 | 446 | 106 | 13 | int:ZNF330 |
| Interaction | H2BC21 interactions | CYLC1 RNF168 ARID4B CHD7 SSRP1 EZH2 HEXIM1 PPM1G LENG8 CTR9 ZNF644 SMARCC1 CRYBG1 DEK TOP2A SENP7 | 7.05e-07 | 696 | 106 | 16 | int:H2BC21 |
| Interaction | CSNK2B interactions | NOLC1 SSRP1 EZH2 HEXIM1 LENG8 CTR9 ZNF644 OSBPL8 AUTS2 UTP3 CLSPN DEK NOS1 TOP2A SNX2 | 9.53e-07 | 625 | 106 | 15 | int:CSNK2B |
| Interaction | H3-3A interactions | SETD1A ARID4B CHD7 SSRP1 EZH2 PPM1G ZNF711 ZNF644 ZNF451 SMARCC1 FGFR1 DEK TOP2A SNX2 SENP7 PPP6R3 | 1.84e-06 | 749 | 106 | 16 | int:H3-3A |
| Interaction | KDM1A interactions | RNF168 CEP162 CAGE1 CHD7 EZH2 DENND4C ESCO2 CEP350 LENG8 FAM161A ZNF644 ZNF451 ARHGAP29 SMARCC1 ZBTB18 ODAD3 ARHGAP21 PPP6R3 | 1.88e-06 | 941 | 106 | 18 | int:KDM1A |
| Interaction | H2BC9 interactions | CYLC1 FRAS1 CUL9 SSRP1 EZH2 HEXIM1 CEP350 TNRC18 DGKK UTP3 DEK TOP2A | 4.00e-06 | 446 | 106 | 12 | int:H2BC9 |
| Interaction | PARP1 interactions | NOLC1 SETD1A RNF168 ARID4B CALD1 CHD7 SSRP1 EZH2 HEXIM1 PPM1G ZNF711 CTR9 ZNF644 ZNF451 SMARCC1 UTP3 CLSPN PLS1 TOP2A SNX2 NOL8 | 4.18e-06 | 1316 | 106 | 21 | int:PARP1 |
| Interaction | CENPA interactions | CHD7 SSRP1 PPM1G ZNF711 ZNF644 ZNF451 SMARCC1 UTP3 DEK TOP2A NOL8 | 4.82e-06 | 377 | 106 | 11 | int:CENPA |
| Interaction | SNRNP40 interactions | GCFC2 SETX CUL9 SSRP1 HEXIM1 LENG8 PRPF3 ZNF644 ZNF451 SMARCC1 UTP3 SNRNP200 TOP2A NOL8 | 6.25e-06 | 637 | 106 | 14 | int:SNRNP40 |
| Interaction | DNAJC17 interactions | 6.92e-06 | 134 | 106 | 7 | int:DNAJC17 | |
| Interaction | CBX3 interactions | SETD1A CHD7 SSRP1 EZH2 PPM1G THOP1 PRPF3 ZNF644 ZNF451 CLSPN DEK TOP2A SENP7 NOL8 | 7.33e-06 | 646 | 106 | 14 | int:CBX3 |
| Interaction | H2BC5 interactions | CYLC1 NOLC1 HEXIM1 PPM1G CEP350 LENG8 TNRC18 SMARCC1 ATG4C TOP2A | 9.85e-06 | 331 | 106 | 10 | int:H2BC5 |
| Interaction | SYT2 interactions | 1.45e-05 | 150 | 106 | 7 | int:SYT2 | |
| Interaction | H2BC13 interactions | 1.53e-05 | 210 | 106 | 8 | int:H2BC13 | |
| Interaction | DNAJB6 interactions | 3.15e-05 | 379 | 106 | 10 | int:DNAJB6 | |
| Interaction | IWS1 interactions | 3.41e-05 | 116 | 106 | 6 | int:IWS1 | |
| Interaction | CCDC71 interactions | 3.87e-05 | 72 | 106 | 5 | int:CCDC71 | |
| Interaction | CHCHD1 interactions | 4.35e-05 | 243 | 106 | 8 | int:CHCHD1 | |
| Interaction | H2BC12 interactions | 5.12e-05 | 322 | 106 | 9 | int:H2BC12 | |
| Interaction | POLR1G interactions | NOLC1 ARID4B CHD7 SSRP1 PPM1G CTR9 ZNF644 UTP3 CLSPN TOP2A NOL8 | 5.35e-05 | 489 | 106 | 11 | int:POLR1G |
| Interaction | CIT interactions | NOLC1 AARS1 SETX SYNE1 SSRP1 CMYA5 EZH2 SYT10 BFSP1 PRPF3 MYH14 CTR9 SMARCC1 UTP3 DEK CSPP1 SNRNP200 PLS1 TOP2A SNX2 | 6.00e-05 | 1450 | 106 | 20 | int:CIT |
| Interaction | SMC5 interactions | NOLC1 SETX ARID4B CALD1 CHD7 SSRP1 ZNF711 LENG8 PRPF3 ZNF644 SMARCC1 UTP3 DEK SNRNP200 TOP2A NOL8 | 6.60e-05 | 1000 | 106 | 16 | int:SMC5 |
| Interaction | SPICE1 interactions | 6.80e-05 | 191 | 106 | 7 | int:SPICE1 | |
| Interaction | TOP2B interactions | 8.19e-05 | 266 | 106 | 8 | int:TOP2B | |
| Interaction | BRCA1 interactions | NOLC1 SETD1A AARS1 SETX RNF168 SSRP1 EZH2 CEP350 PRPF3 MYH14 FAM161A SMARCC1 CLSPN SNRNP200 ARHGAP21 TOP2A PPP6R3 REV1 | 8.52e-05 | 1249 | 106 | 18 | int:BRCA1 |
| Interaction | BRD2 interactions | 8.88e-05 | 429 | 106 | 10 | int:BRD2 | |
| Interaction | POLR1E interactions | 9.70e-05 | 350 | 106 | 9 | int:POLR1E | |
| Interaction | HNF4A interactions | 1.03e-04 | 275 | 106 | 8 | int:HNF4A | |
| Interaction | ARID1A interactions | 1.06e-04 | 276 | 106 | 8 | int:ARID1A | |
| Interaction | APEX1 interactions | NOLC1 GCFC2 ARID4B CEP162 THUMPD3 CHD7 ZNF711 LENG8 ZNF644 POLI SMARCC1 FGFR1 RPGR UTP3 DEK PLS1 SENP7 NOL8 | 1.06e-04 | 1271 | 106 | 18 | int:APEX1 |
| Interaction | SIRT6 interactions | SETD1A SSRP1 LENG8 PRPF3 MYH14 CTR9 ZNF644 SMARCC1 UTP3 SNRNP200 TOP2A PPP6R3 | 1.15e-04 | 628 | 106 | 12 | int:SIRT6 |
| Interaction | ARL4D interactions | 1.23e-04 | 146 | 106 | 6 | int:ARL4D | |
| Interaction | NFKBIL1 interactions | 1.32e-04 | 93 | 106 | 5 | int:NFKBIL1 | |
| Interaction | H2AC18 interactions | 1.32e-04 | 148 | 106 | 6 | int:H2AC18 | |
| Interaction | SUZ12 interactions | NOLC1 SETD1A AARS1 SETX SYNE1 CHD7 SSRP1 PARP14 EZH2 MYH14 SMARCC1 SNRNP200 | 1.45e-04 | 644 | 106 | 12 | int:SUZ12 |
| Interaction | H2AZ1 interactions | RNF168 ARID4B SSRP1 PARP14 HEXIM1 PPM1G ZNF644 SMARCC1 TOP2A | 1.51e-04 | 371 | 106 | 9 | int:H2AZ1 |
| Interaction | TERF2IP interactions | SETD1A SETX CHD7 SSRP1 EZH2 PPM1G ZNF644 SMARCC1 CLSPN TOP2A PPP6R3 | 1.56e-04 | 552 | 106 | 11 | int:TERF2IP |
| Interaction | CDK8 interactions | 1.73e-04 | 222 | 106 | 7 | int:CDK8 | |
| Interaction | GATAD2A interactions | 1.83e-04 | 224 | 106 | 7 | int:GATAD2A | |
| Interaction | HADHA interactions | ACAD9 CUL9 EZH2 HEXIM1 PPM1G OSBPL8 FGFR1 FGFR3 DNAI7 SNRNP200 PPP6R3 | 1.97e-04 | 567 | 106 | 11 | int:HADHA |
| Interaction | WASHC4 interactions | 2.03e-04 | 102 | 106 | 5 | int:WASHC4 | |
| Interaction | NOP56 interactions | 2.06e-04 | 570 | 106 | 11 | int:NOP56 | |
| Interaction | DDX23 interactions | 2.21e-04 | 480 | 106 | 10 | int:DDX23 | |
| Interaction | H2BC8 interactions | ARID4B CHD7 SSRP1 PPM1G ZNF711 ESCO2 ZNF644 SMARCC1 UTP3 DEK TOP2A | 2.26e-04 | 576 | 106 | 11 | int:H2BC8 |
| Interaction | SNRPA interactions | SSRP1 EZH2 HEXIM1 PPM1G LENG8 PRPF3 CTR9 SNRNP200 TOP2A TGS1 | 2.29e-04 | 482 | 106 | 10 | int:SNRPA |
| Interaction | SSRP1 interactions | NOLC1 SETX SSRP1 EZH2 HEXIM1 PRPF3 CTR9 ZNF644 SMARCC1 CLSPN SNRNP200 TOP2A | 2.57e-04 | 685 | 106 | 12 | int:SSRP1 |
| Interaction | YWHAG interactions | NOLC1 AARS1 SASH1 CEP162 SH3GL1 MPDZ EZH2 DENND4C HEXIM1 CEP350 ARHGAP29 OSBPL8 CSPP1 SNRNP200 ARHGAP21 SNX2 PPP6R3 | 2.68e-04 | 1248 | 106 | 17 | int:YWHAG |
| Interaction | FSAF1 interactions | 2.81e-04 | 60 | 106 | 4 | int:FSAF1 | |
| Interaction | H3C3 interactions | 2.83e-04 | 495 | 106 | 10 | int:H3C3 | |
| Interaction | PCNT interactions | 2.86e-04 | 241 | 106 | 7 | int:PCNT | |
| Interaction | CSNK2A3 interactions | 2.89e-04 | 110 | 106 | 5 | int:CSNK2A3 | |
| Interaction | EIF4A3 interactions | AARS1 GCFC2 CUL9 SSRP1 EZH2 HEXIM1 PRPF3 ZNF451 SNRNP200 PPP6R3 | 3.01e-04 | 499 | 106 | 10 | int:EIF4A3 |
| Interaction | CHAF1A interactions | 3.02e-04 | 322 | 106 | 8 | int:CHAF1A | |
| Interaction | SUPT5H interactions | 3.04e-04 | 408 | 106 | 9 | int:SUPT5H | |
| Interaction | NSUN2 interactions | 3.09e-04 | 323 | 106 | 8 | int:NSUN2 | |
| Interaction | DHX40 interactions | 3.48e-04 | 249 | 106 | 7 | int:DHX40 | |
| Interaction | EP300 interactions | SETD1A FRAS1 GCFC2 ACAD9 RTN4 SSRP1 EZH2 PPM1G ZBTB49 PRPF3 CTR9 POLI AUTS2 SMARCC1 DEK SNRNP200 TOP2A TGS1 | 3.54e-04 | 1401 | 106 | 18 | int:EP300 |
| Interaction | KAT6A interactions | RNF168 SSRP1 HEXIM1 CEP350 PRPF3 CTR9 UTP3 DEK SNRNP200 TOP2A | 3.58e-04 | 510 | 106 | 10 | int:KAT6A |
| Interaction | CEP63 interactions | 3.70e-04 | 179 | 106 | 6 | int:CEP63 | |
| Interaction | ZNF677 interactions | 3.77e-04 | 27 | 106 | 3 | int:ZNF677 | |
| Interaction | KIFBP interactions | 3.81e-04 | 180 | 106 | 6 | int:KIFBP | |
| Interaction | CSNK2A2 interactions | NOLC1 GCFC2 ARID4B SSRP1 HEXIM1 PPM1G CTR9 ARHGAP29 OSBPL8 AUTS2 DEK TOP2A | 3.93e-04 | 718 | 106 | 12 | int:CSNK2A2 |
| Interaction | DGKK interactions | 4.05e-04 | 6 | 106 | 2 | int:DGKK | |
| Interaction | FGF3 interactions | 4.06e-04 | 66 | 106 | 4 | int:FGF3 | |
| Interaction | RABEP1 interactions | 4.28e-04 | 184 | 106 | 6 | int:RABEP1 | |
| Interaction | ELK3 interactions | 4.32e-04 | 120 | 106 | 5 | int:ELK3 | |
| Interaction | TERF2 interactions | 4.34e-04 | 340 | 106 | 8 | int:TERF2 | |
| Interaction | H2BC4 interactions | 4.41e-04 | 259 | 106 | 7 | int:H2BC4 | |
| Interaction | NUP43 interactions | SETD1A SETX ARID4B SSRP1 ZNF711 ZNF644 SMARCC1 UTP3 DNAH9 SNRNP200 TOP2A | 4.51e-04 | 625 | 106 | 11 | int:NUP43 |
| Interaction | MTA2 interactions | 4.85e-04 | 435 | 106 | 9 | int:MTA2 | |
| Interaction | FGFR1 interactions | ANK3 SH3GL1 DENND4C HEXIM1 ZFYVE9 ARHGAP29 OSBPL8 FGFR1 FGFR3 PLS1 SNX2 | 4.95e-04 | 632 | 106 | 11 | int:FGFR1 |
| Interaction | TP53BP1 interactions | SETD1A SETX RNF168 EZH2 HEXIM1 PPM1G ZNF451 SMARCC1 DEK NOL8 | 5.06e-04 | 533 | 106 | 10 | int:TP53BP1 |
| Interaction | FBXO22 interactions | AARS1 ANK3 MYO7A ACAD9 RTN4 OSBPL8 UTP3 DNAI7 CSPP1 ARHGAP21 | 5.60e-04 | 540 | 106 | 10 | int:FBXO22 |
| Interaction | E2F4 interactions | NOLC1 ANK3 RTN4 SH3GL1 SSRP1 HEXIM1 PPM1G SMARCC1 UTP3 TOP2A | 5.60e-04 | 540 | 106 | 10 | int:E2F4 |
| Interaction | FGF6 interactions | 5.66e-04 | 7 | 106 | 2 | int:FGF6 | |
| Interaction | FGF18 interactions | 5.66e-04 | 7 | 106 | 2 | int:FGF18 | |
| Interaction | TNIP1 interactions | NOLC1 AARS1 RNF168 CALD1 SYNE1 SSRP1 BFSP1 LENG8 PRPF3 MYH14 FAM161A UTP3 DEK SNRNP200 PLS1 TOP2A | 6.09e-04 | 1217 | 106 | 16 | int:TNIP1 |
| Interaction | MKI67 interactions | SETD1A FRAS1 RNF168 CHD7 PARP14 EZH2 LENG8 PRPF3 MYH14 UTP3 SNRNP200 | 6.10e-04 | 648 | 106 | 11 | int:MKI67 |
| Interaction | HDAC2 interactions | AARS1 ARID4B ACAD9 PARP14 EZH2 DENND4C HEXIM1 ESCO2 ZNF644 SMARCC1 DEK TOP2A PPP6R3 | 6.10e-04 | 865 | 106 | 13 | int:HDAC2 |
| Interaction | PLCD4 interactions | 6.28e-04 | 32 | 106 | 3 | int:PLCD4 | |
| Interaction | ARID4B interactions | 6.47e-04 | 199 | 106 | 6 | int:ARID4B | |
| GeneFamily | N-BAR domain containing | 9.78e-04 | 12 | 71 | 2 | 1289 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.18e-03 | 53 | 71 | 3 | 532 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SCHIP1 SETX SASH1 CEP350 ZFYVE9 MIA2 ZNF451 ARHGAP29 OSBPL8 RPGR ZBTB18 DEK TOP2A SNX2 | 8.25e-06 | 856 | 105 | 14 | M4500 |
| Coexpression | VERNELL_RETINOBLASTOMA_PATHWAY_UP | 8.59e-06 | 69 | 105 | 5 | M15969 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | SETX ARID4B DENND4C CEP350 CTR9 ARHGAP29 OSBPL8 DEK SNX2 REV1 | 8.98e-06 | 429 | 105 | 10 | M29 |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN | 1.59e-05 | 199 | 105 | 7 | M7998 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 3.14e-05 | 304 | 105 | 8 | M39113 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP | 4.29e-05 | 158 | 105 | 6 | M8888 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 GCFC2 SETX RNF168 ARID4B EZH2 ZNF711 ESCO2 CEP350 MYH14 ZNF644 AUTS2 SMARCC1 RPGR UTP3 CLSPN DEK CSPP1 ARHGAP21 TOP2A NOL8 TGS1 | 1.75e-07 | 1257 | 105 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 GCFC2 SETX RNF168 ARID4B CHD7 EZH2 ZNF711 ESCO2 CEP350 MYH14 ZNF644 AUTS2 SMARCC1 RPGR UTP3 CLSPN DEK CSPP1 ARHGAP21 TOP2A NOL8 TGS1 | 5.57e-07 | 1459 | 105 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CELF4 RNF168 ARID4B CHD7 SSRP1 ZNF711 ZFYVE9 RPGR CLSPN DEK CSPP1 SNRNP200 SDK1 TOP2A | 1.39e-06 | 595 | 105 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.32e-06 | 311 | 105 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | GCFC2 SETX ARID4B CEP162 CHD7 EZH2 ZNF711 MYH14 ZNF644 ELAPOR1 SMARCC1 RPGR CLSPN ZBTB18 DEK CSPP1 NOL8 TGS1 | 4.18e-06 | 1060 | 105 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | GCFC2 SETX ARID4B CEP162 SH3GL2 CHD7 EZH2 ZNF711 LHX1 MYH14 ZNF644 ELAPOR1 SMARCC1 FGFR3 RPGR CLSPN ZBTB18 DEK CSPP1 NOL8 TGS1 | 4.86e-06 | 1414 | 105 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.09e-06 | 192 | 105 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SETX ARID4B CALD1 CHD7 EZH2 ZNF711 ESCO2 MIA2 MYH14 CTR9 ZNF644 DGKK ELAPOR1 SMARCC1 RPGR CLSPN DEK SENP7 TGS1 | 1.10e-05 | 1252 | 105 | 19 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SETX RNF168 CHD7 ZFYVE9 MYH14 SMARCC1 UTP3 CLSPN DEK NOL8 TGS1 | 2.09e-05 | 469 | 105 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | SETX ARID4B CALD1 TSHZ2 SH3GL2 CHD7 LHX1 MYH14 ZNF644 ELAPOR1 RPGR CLSPN ZBTB18 PLS1 SENP7 NOL8 | 2.44e-05 | 979 | 105 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 RNF168 ARID4B CEP162 CHD7 EZH2 LHX1 DMRT3 ELAPOR1 FGFR3 RPGR CLSPN DEK ARHGAP21 NOL8 TGS1 | 2.76e-05 | 989 | 105 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NOLC1 SETX ARID4B CALD1 ANK3 CHD7 EZH2 ZNF711 MYH14 ZNF644 DGKK SMARCC1 RPGR CLSPN DEK TOP2A NOL8 TGS1 | 3.52e-05 | 1241 | 105 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RNF168 CHD7 EZH2 LHX1 DMRT3 ELAPOR1 FGFR3 CLSPN DEK NOL8 TGS1 | 3.62e-05 | 498 | 105 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | GCFC2 ARID4B CEP162 CHD7 EZH2 ZNF711 ESCO2 MYH14 DGKK AUTS2 CLSPN ZBTB18 DEK CSPP1 ARHGAP21 TOP2A SENP7 TGS1 REV1 | 3.82e-05 | 1370 | 105 | 19 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SETD1A CALD1 NBEAL1 CHD7 ZNF711 ESCO2 LHX1 ZNF451 SMARCC1 RPGR CSPP1 TOP2A SENP7 TGS1 | 4.84e-05 | 815 | 105 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SETX RTN4 THUMPD3 CHD7 DMRT3 MIA2 ELAPOR1 SMARCC1 UTP3 CLSPN NOL8 | 6.56e-05 | 532 | 105 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NOLC1 SETX ARID4B CALD1 ANK3 CHD7 EZH2 ZNF711 MYH14 ZNF644 DGKK ELAPOR1 SMARCC1 RPGR CLSPN DEK TOP2A NOL8 TGS1 | 9.64e-05 | 1468 | 105 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | RNF168 ARID4B SYNE1 MPDZ CHD7 ZNF711 LHX1 MYH14 RPGR CLSPN DEK CSPP1 PLS1 SENP7 PPP6R3 | 1.04e-04 | 989 | 105 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.18e-04 | 298 | 105 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.56e-04 | 232 | 105 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | SETX THUMPD3 ESCO2 LHX1 PRPF3 CTR9 ZNF451 POLI CLSPN CSPP1 PLS1 NOL8 REV1 | 1.80e-04 | 810 | 105 | 13 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.22e-04 | 173 | 105 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 2.27e-04 | 417 | 105 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.51e-04 | 333 | 105 | 8 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.66e-04 | 123 | 105 | 5 | gudmap_developingGonad_e12.5_epididymis_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.86e-04 | 564 | 105 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SETD1A CALD1 TSHZ2 NBEAL1 ZNF711 LHX1 TNRC18 ZNF451 SMARCC1 CSPP1 SENP7 TGS1 | 6.00e-04 | 801 | 105 | 12 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SETD1A CALD1 NBEAL1 ZNF711 ESCO2 ZNF451 ARHGAP29 SMARCC1 RPGR CSPP1 SENP7 TGS1 | 6.20e-04 | 804 | 105 | 12 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SETD1A CALD1 ESCO2 LHX1 TNRC18 ZNF451 SMARCC1 CSPP1 TOP2A SENP7 NOL8 TGS1 | 6.33e-04 | 806 | 105 | 12 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.04e-04 | 298 | 105 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SETX ESCO2 ZFYVE9 PRPF3 ZNF451 DGKK POLI RPGR CLSPN PLS1 NOL8 REV1 | 7.36e-04 | 820 | 105 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.65e-08 | 199 | 106 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 179 | 106 | 7 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 179 | 106 | 7 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-07 | 179 | 106 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-07 | 185 | 106 | 7 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-07 | 193 | 106 | 7 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.37e-07 | 195 | 106 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.37e-07 | 195 | 106 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.53e-07 | 196 | 106 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.53e-07 | 196 | 106 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL|Int-URO / Disease, condition lineage and cell class | 4.85e-07 | 198 | 106 | 7 | 717735d755745439f97ba1b71785c73945dfa9c5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-06 | 163 | 106 | 6 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 164 | 106 | 6 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.90e-06 | 166 | 106 | 6 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-06 | 173 | 106 | 6 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.93e-06 | 175 | 106 | 6 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.33e-06 | 178 | 106 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.33e-06 | 178 | 106 | 6 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.24e-06 | 184 | 106 | 6 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.41e-06 | 185 | 106 | 6 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 186 | 106 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.57e-06 | 186 | 106 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.57e-06 | 186 | 106 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-06 | 187 | 106 | 6 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 5.93e-06 | 188 | 106 | 6 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.93e-06 | 188 | 106 | 6 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 191 | 106 | 6 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.89e-06 | 193 | 106 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.89e-06 | 193 | 106 | 6 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | ae6d5cf4c825b29e677296df2c0985431c83b82e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-06 | 194 | 106 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.09e-06 | 194 | 106 | 6 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-06 | 194 | 106 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-06 | 194 | 106 | 6 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-06 | 194 | 106 | 6 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.09e-06 | 194 | 106 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.30e-06 | 195 | 106 | 6 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 7.30e-06 | 195 | 106 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.30e-06 | 195 | 106 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.30e-06 | 195 | 106 | 6 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.30e-06 | 195 | 106 | 6 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 195 | 106 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.52e-06 | 196 | 106 | 6 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 7.52e-06 | 196 | 106 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.74e-06 | 197 | 106 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.74e-06 | 197 | 106 | 6 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-06 | 197 | 106 | 6 | d9978aaa476b57144b0561f535ff1dd886c7512b | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 7.74e-06 | 197 | 106 | 6 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.97e-06 | 198 | 106 | 6 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 198 | 106 | 6 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 7.97e-06 | 198 | 106 | 6 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 198 | 106 | 6 | c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.97e-06 | 198 | 106 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.97e-06 | 198 | 106 | 6 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.97e-06 | 198 | 106 | 6 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 198 | 106 | 6 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 8.20e-06 | 199 | 106 | 6 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.20e-06 | 199 | 106 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.20e-06 | 199 | 106 | 6 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-06 | 199 | 106 | 6 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.20e-06 | 199 | 106 | 6 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.20e-06 | 199 | 106 | 6 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | B_cell_maturation-pre-B|B_cell_maturation / Lineage and Cell class | 8.20e-06 | 199 | 106 | 6 | 4bf6a656de04d92103cbe743cd07afd9d125c654 | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 8.20e-06 | 199 | 106 | 6 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.20e-06 | 199 | 106 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.20e-06 | 199 | 106 | 6 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 8.20e-06 | 199 | 106 | 6 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 8.20e-06 | 199 | 106 | 6 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 8.20e-06 | 199 | 106 | 6 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-06 | 199 | 106 | 6 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-06 | 199 | 106 | 6 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.20e-06 | 199 | 106 | 6 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.20e-06 | 199 | 106 | 6 | 53b3d35767889a152f1f38e8f6f0ba8f7a7690f2 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 8.44e-06 | 200 | 106 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.44e-06 | 200 | 106 | 6 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.44e-06 | 200 | 106 | 6 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 8.44e-06 | 200 | 106 | 6 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 8.44e-06 | 200 | 106 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 8.44e-06 | 200 | 106 | 6 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.44e-06 | 200 | 106 | 6 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 8.44e-06 | 200 | 106 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.44e-06 | 200 | 106 | 6 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 140 | 106 | 5 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 141 | 106 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 141 | 106 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-05 | 143 | 106 | 5 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.98e-05 | 150 | 106 | 5 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.17e-05 | 152 | 106 | 5 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-05 | 162 | 106 | 5 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 4.43e-05 | 163 | 106 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-05 | 164 | 106 | 5 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.61e-07 | 197 | 106 | 9 | 4382_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.13e-06 | 198 | 106 | 8 | 4551_DN | |
| Disease | Brachycephaly | 2.87e-05 | 17 | 105 | 3 | C0221356 | |
| Disease | autosomal dominant intellectual developmental disorder (implicated_via_orthology) | 3.75e-05 | 3 | 105 | 2 | DOID:0060307 (implicated_via_orthology) | |
| Disease | TWIST1-related craniosynostosis | 7.49e-05 | 4 | 105 | 2 | cv:C4551902 | |
| Disease | Disorder of eye | 1.14e-04 | 212 | 105 | 6 | C0015397 | |
| Disease | Partial Fetal Alcohol Syndrome | 1.25e-04 | 5 | 105 | 2 | C3661483 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 1.25e-04 | 5 | 105 | 2 | C0814154 | |
| Disease | bone disease (implicated_via_orthology) | 1.25e-04 | 5 | 105 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Retinitis pigmentosa | 1.44e-04 | 74 | 105 | 4 | cv:C0035334 | |
| Disease | Kallmann Syndrome 2 (disorder) | 1.86e-04 | 6 | 105 | 2 | C1563720 | |
| Disease | Kallmann Syndrome 1 | 1.86e-04 | 6 | 105 | 2 | C1563719 | |
| Disease | Hypogonadism with anosmia | 1.86e-04 | 6 | 105 | 2 | cv:C0162809 | |
| Disease | Kallmann syndrome, type 3, recessive | 1.86e-04 | 6 | 105 | 2 | C2930927 | |
| Disease | Alcohol Related Birth Defect | 1.86e-04 | 6 | 105 | 2 | C3146244 | |
| Disease | hydrocephalus (is_implicated_in) | 1.86e-04 | 6 | 105 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Craniosynostosis syndrome | 2.60e-04 | 7 | 105 | 2 | cv:C0010278 | |
| Disease | Kartagener Syndrome | 2.64e-04 | 35 | 105 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 2.64e-04 | 35 | 105 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 2.64e-04 | 35 | 105 | 3 | C4317124 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.06e-04 | 90 | 105 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | hearing impairment | 4.23e-04 | 98 | 105 | 4 | C1384666 | |
| Disease | Congenital small ears | 4.23e-04 | 41 | 105 | 3 | C0152423 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 4.23e-04 | 41 | 105 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | SYNE1 EZH2 MIA2 OTOGL ZNF644 ELAPOR1 ARHGAP29 FGFR1 CLSPN DEK DNAH9 TOP2A | 4.42e-04 | 1074 | 105 | 12 | C0006142 |
| Disease | high grade glioma (implicated_via_orthology) | 5.22e-04 | 44 | 105 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Retinitis Pigmentosa | 5.30e-04 | 104 | 105 | 4 | C0035334 | |
| Disease | Epilepsy | 6.32e-04 | 109 | 105 | 4 | C0014544 | |
| Disease | Primary Ciliary Dyskinesia | 6.34e-04 | 47 | 105 | 3 | C4551720 | |
| Disease | cocaine use | 6.76e-04 | 11 | 105 | 2 | C3496069 | |
| Disease | Polydactyly | 8.24e-04 | 117 | 105 | 4 | C0152427 | |
| Disease | Fetal Alcohol Spectrum Disorders | 9.54e-04 | 13 | 105 | 2 | C2985290 | |
| Disease | Synostotic Posterior Plagiocephaly | 1.46e-03 | 16 | 105 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.46e-03 | 16 | 105 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.46e-03 | 16 | 105 | 2 | C0030044 | |
| Disease | gliosarcoma | 1.46e-03 | 16 | 105 | 2 | C0206726 | |
| Disease | Trigonocephaly | 1.46e-03 | 16 | 105 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.46e-03 | 16 | 105 | 2 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.46e-03 | 16 | 105 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.46e-03 | 16 | 105 | 2 | C1860819 | |
| Disease | Fetal Alcohol Syndrome | 1.65e-03 | 17 | 105 | 2 | C0015923 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 1.85e-03 | 18 | 105 | 2 | C0342384 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.86e-03 | 68 | 105 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | synophrys measurement | 1.86e-03 | 68 | 105 | 3 | EFO_0007906 | |
| Disease | Craniosynostosis | 2.29e-03 | 20 | 105 | 2 | C0010278 | |
| Disease | psychotic symptoms | 2.36e-03 | 74 | 105 | 3 | EFO_0005940 | |
| Disease | Headache, HbA1c measurement | 2.52e-03 | 21 | 105 | 2 | EFO_0004541, HP_0002315 | |
| Disease | smoking status measurement | NOLC1 CELF4 TSHZ2 SH3GL1 CHD7 STARD3 AUTS2 SMARCC1 FGFR1 UNC79 SDK1 | 2.83e-03 | 1160 | 105 | 11 | EFO_0006527 |
| Disease | cortical surface area measurement | ANK3 NBEAL1 CEP162 CUL9 CHD7 DMRT3 AUTS2 FGFR1 FGFR3 ZBTB18 PLS1 ARHGAP21 | 3.00e-03 | 1345 | 105 | 12 | EFO_0010736 |
| Disease | Immunologic Deficiency Syndromes | 3.02e-03 | 23 | 105 | 2 | C0021051 | |
| Disease | Nonsyndromic Deafness | 3.05e-03 | 81 | 105 | 3 | C3711374 | |
| Disease | Cleft Palate | 3.05e-03 | 81 | 105 | 3 | C0008925 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.39e-03 | 84 | 105 | 3 | DOID:9119 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTELKEDSSSSEAEE | 266 | Q4LE39 | |
| SDAEHFKESEKVSDI | 636 | Q8TC20 | |
| ELKDRETFKAEDVSS | 786 | Q9BXX2 | |
| EKAEAEASEDTKAQS | 6 | Q76N32 | |
| EITEQFASSKEADEK | 346 | Q8WW27 | |
| SDFIDKAEESTQSKE | 656 | Q2M3G0 | |
| FAKTEVVDSDGSVKD | 226 | Q9H845 | |
| FAKEEEFPSSESKSE | 711 | Q8TC27 | |
| ADTSKSKSEDSAEAY | 756 | Q8TC27 | |
| EDENKDSEKSTDAVS | 2851 | Q9P2D1 | |
| TTTNEEDLFSEDEKK | 431 | Q96DT6 | |
| NSDEKTDEEKITSFA | 1306 | Q6ZS30 | |
| SSEDSSSDEEEEQKK | 266 | Q14978 | |
| EKSATEYADSSKADR | 731 | Q5KSL6 | |
| KAVDADTEAESVTFT | 2336 | Q86XX4 | |
| FTACESEEDKDRTEK | 301 | Q96PV6 | |
| GEDVEDDLIFTSKKS | 966 | Q6UXG2 | |
| SKRAAAKSDDTSDDD | 226 | O94992 | |
| EEEEKKDETSSSSEA | 396 | Q15910 | |
| AEFSSQAAEEEEKVK | 1026 | Q7Z406 | |
| SVADSNKDGKISFEE | 61 | Q14651 | |
| KDARKDTESTDAEFD | 511 | P35663 | |
| EESSEKFRQVEKSTE | 191 | Q1MSJ5 | |
| DQEEKASDASSEKLF | 226 | Q8WXX7 | |
| DDAKDSESANVSDKE | 151 | P48742 | |
| DESDSEDDSNRFKIK | 841 | Q76FK4 | |
| ESIAFIEESKKDTDE | 1416 | P29475 | |
| SEVFITDKKTDNSEV | 641 | Q9BZF1 | |
| DVSEKTVEAFAEAVK | 961 | Q460N5 | |
| SSTSEEEEAFTEKFL | 201 | Q8N573 | |
| KEDIHTSESESKIFE | 931 | Q52LW3 | |
| KSVEEFMDSSVEDSK | 526 | P16383 | |
| DDDSSSEEKETDNTK | 131 | P11362 | |
| GKSADNTEVFSDKDT | 161 | Q9NQL9 | |
| SSKKESESEDSSDDE | 296 | P35659 | |
| EESESKFESESKEVS | 406 | Q12934 | |
| KTGEAVAEKDSEITF | 1586 | P01031 | |
| SSKSYSSEEVKLAEE | 1976 | Q8N3K9 | |
| SSDDSSDEDKLKIAD | 1016 | Q6PD62 | |
| SEDFEVSSFKKEISA | 2376 | Q5VT06 | |
| KEESEAFSEALKEET | 656 | Q6TDU7 | |
| KGTEKTDKVDFDSAE | 656 | Q5VZ89 | |
| DDEVFDSKSREDETK | 3551 | Q12955 | |
| SEKVAERKETEFFSS | 371 | Q5TB80 | |
| IEDSDVETVSEKKTF | 241 | Q56NI9 | |
| EKISDSKDFSDHLDS | 471 | Q8NFN8 | |
| SSDKLTVSSEEKVFE | 201 | Q9UH77 | |
| GKFEDEQEVFSESKS | 806 | Q9ULL0 | |
| EASFSEEETESLKAK | 601 | Q8IWT3 | |
| EFADSKSETVLDSID | 196 | Q9NYC9 | |
| EKEDSEAADSKSLVL | 406 | Q9Y4K1 | |
| KDDATDKDLSDLVSE | 511 | P22607 | |
| SVTEDKESFNEEEKI | 606 | Q3B820 | |
| SFSEEDSFKKCSSEV | 326 | Q9UNA4 | |
| VTDLSDDSDFDEKAK | 361 | Q9NQZ2 | |
| LKEKSADASESEATD | 2116 | Q7Z5N4 | |
| LKEVFGDDSEISKES | 91 | O43395 | |
| TDSSVKASKYDDSEE | 1336 | Q3ZCN5 | |
| VESSLKDASFEKEAT | 716 | Q96PC5 | |
| TDKAEDHEFSKTEEL | 836 | Q92834 | |
| EDEVVSSEKAKDSFN | 356 | Q9NQC3 | |
| TKKQEDDSTISTEFE | 326 | Q9BQF6 | |
| VGKEDSSSTEFVEKR | 221 | O60749 | |
| DVESKRSDKTDFAEQ | 6981 | Q8NF91 | |
| DKDSDADDSKTETSL | 311 | P0DPB3 | |
| ATSKDKFFDEESEEE | 551 | A5D8V7 | |
| VAKSKFFEDSEDESD | 251 | O15355 | |
| EKVSTSNEDFSLKDD | 756 | Q7Z333 | |
| EEAVDTTKKETEVSD | 991 | O15047 | |
| SEKEQDSEVSEDTKS | 816 | Q92922 | |
| DSEVSEDTKSEEKET | 821 | Q92922 | |
| SDEEVAGKKSFSAQE | 221 | Q14849 | |
| DFSSESDLEESKEKL | 1131 | P35498 | |
| ESSCDVKLVEKSFET | 91 | P01848 | |
| LSESFKSKEFVSSDE | 656 | Q08945 | |
| ETEETFVKAETEKSD | 341 | P08912 | |
| TAENETTEKEEKSES | 141 | Q05682 | |
| ASSSLVVKFADTDKE | 221 | Q9BZC1 | |
| LSEGDSDEEIFVSKK | 41 | Q9HAW4 | |
| FKETSHESVDSSKEE | 256 | Q5SXH7 | |
| EEEAAVVAASSSKKA | 536 | O15417 | |
| FVSEKTETSIKTEDD | 696 | Q9Y4E5 | |
| ALEKFEESKEVAETS | 186 | Q99961 | |
| SASKISQDVDKEDEF | 1316 | O75970 | |
| VDDSSEDKTEFTVKN | 551 | P49588 | |
| AFSQEEDKAEKSSTD | 256 | Q9UBZ9 | |
| EDKAEKSSTDFRDCT | 261 | Q9UBZ9 | |
| ESSCDVKLVEKSFET | 226 | P0DTU3 | |
| ALEKFDESKEIAESS | 186 | Q99962 | |
| ATTEADSTKKEEDAS | 121 | Q99592 | |
| EQSDDETEESVKFKR | 246 | O94885 | |
| SSAPTEVFETEEKKE | 101 | Q6XYQ8 | |
| PETIAAEEDTDSKFK | 981 | Q9NRE2 | |
| EVRKDSVSKDIDSSD | 246 | Q8IYW5 | |
| SASSAKEDEKESSDE | 871 | Q96JE7 | |
| ASCKDETDESSKEET | 206 | Q9BV44 | |
| SAEKKDSYETEDESS | 846 | Q9H582 | |
| KFSVDVKEAETDSDS | 2121 | O75643 | |
| SDNEKETEKSDSVTD | 1106 | P11388 | |
| TEEEDFECSENKKSF | 296 | Q9UL58 | |
| EKASSQSAEEKESEE | 346 | Q6ZSB9 | |
| DTYTSKTEADDKNDE | 271 | Q96RS0 | |
| IKTEDDDDDDVKSTS | 186 | Q9Y462 | |
| TASTEADKKLSEFDV | 96 | P52888 | |
| RKDSSSEVFSDAAKE | 921 | Q5T5U3 | |
| VDAKTETAVFKSEEG | 806 | Q5H9R7 | |
| SVTEEKEIEESKSEC | 501 | O95405 | |
| QVSVEDCSKDFSSKD | 1686 | Q9P2D8 | |
| DTDEAFEVESSTKAK | 1911 | Q13402 |